Indoco Remedies Limited (NSE:INDOCO)

Indoco Remedies Statistics

Total Valuation

Indoco Remedies has a market cap or net worth of INR 19.41 billion. The enterprise value is 29.14 billion.

Market Cap	19.41B
Enterprise Value	29.14B

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Sep 4, 2025

Share Statistics

Indoco Remedies has 92.25 million shares outstanding. The number of shares has increased by 14.53% in one year.

Current Share Class	92.25M
Shares Outstanding	92.25M
Shares Change (YoY)	+14.53%
Shares Change (QoQ)	-12.70%
Owned by Insiders (%)	22.36%
Owned by Institutions (%)	20.88%
Float	36.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	53.77
PS Ratio	1.12
PB Ratio	1.99
P/TBV Ratio	2.47
P/FCF Ratio	n/a
P/OCF Ratio	13.78
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 46.67, with an EV/FCF ratio of -30.36.

EV / Earnings	-26.37
EV / Sales	1.69
EV / EBITDA	46.67
EV / EBIT	n/a
EV / FCF	-30.36

Financial Position

The company has a current ratio of 1.10, with a Debt / Equity ratio of 1.03.

Current Ratio	1.10
Quick Ratio	0.50
Debt / Equity	1.03
Debt / EBITDA	15.99
Debt / FCF	-10.40
Interest Coverage	-0.58

Financial Efficiency

Return on equity (ROE) is -11.18% and return on invested capital (ROIC) is -1.50%.

Return on Equity (ROE)	-11.18%
Return on Assets (ROA)	-1.20%
Return on Invested Capital (ROIC)	-1.50%
Return on Capital Employed (ROCE)	-3.08%
Weighted Average Cost of Capital (WACC)	6.46%
Revenue Per Employee	2.88M
Profits Per Employee	-184,178
Employee Count	6,000
Asset Turnover	0.70
Inventory Turnover	1.38

Taxes

Income Tax	-113.69M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.75% in the last 52 weeks. The beta is 0.41, so Indoco Remedies's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-26.75%
50-Day Moving Average	238.62
200-Day Moving Average	270.46
Relative Strength Index (RSI)	36.79
Average Volume (20 Days)	33,273

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Indoco Remedies had revenue of INR 17.25 billion and -1.11 billion in losses. Loss per share was -11.34.

Revenue	17.25B
Gross Profit	11.68B
Operating Income	-468.90M
Pretax Income	-1.27B
Net Income	-1.11B
EBITDA	577.89M
EBIT	-468.90M
Loss Per Share	-11.34

Balance Sheet

The company has 193.20 million in cash and 9.99 billion in debt, with a net cash position of -9.79 billion or -106.17 per share.

Cash & Cash Equivalents	193.20M
Total Debt	9.99B
Net Cash	-9.79B
Net Cash Per Share	-106.17
Equity (Book Value)	9.74B
Book Value Per Share	123.55
Working Capital	962.60M

Cash Flow

In the last 12 months, operating cash flow was 1.41 billion and capital expenditures -2.37 billion, giving a free cash flow of -959.96 million.

Operating Cash Flow	1.41B
Capital Expenditures	-2.37B
Free Cash Flow	-959.96M
FCF Per Share	-10.41

Margins

Gross margin is 67.68%, with operating and profit margins of -2.72% and -6.41%.

Gross Margin	67.68%
Operating Margin	-2.72%
Pretax Margin	-7.34%
Profit Margin	-6.41%
EBITDA Margin	3.35%
EBIT Margin	-2.72%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.09%.

Dividend Per Share	0.20
Dividend Yield	0.09%
Dividend Growth (YoY)	-86.67%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.53%
Shareholder Yield	-14.43%
Earnings Yield	-5.69%
FCF Yield	-4.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 17, 2012. It was a forward split with a ratio of 7.5.

Last Split Date	May 17, 2012
Split Type	Forward
Split Ratio	7.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	3